Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin

被引：0
|
作者：
Samanta, A
Mandalapu, A
Fisher, A
Wilson, D
de la Torre, A
Klein, KM
Koneru, B
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A455 / A456
页数：2
相关论文
共 50 条
  • [41] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [42] Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4.
    Esmat, G
    Abouzied, AM
    Abdel-Aziz, F
    Mohamed, MK
    Abdel-Hamid, M
    El Raziky, MS
    Ismail, SA
    Zalata, KR
    Mikhail, NN
    Fix, A
    Strickland, T
    Sjogren, MH
    HEPATOLOGY, 2002, 36 (04) : 364A - 364A
  • [43] Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children:: Efficacy, safety, and pharmacokinetics
    González-Peralta, RP
    Kelly, DA
    Haber, B
    Molleston, J
    Murray, KF
    Jonas, MM
    Shelton, M
    Mieli-Vergani, G
    Lurie, Y
    Martin, S
    Lang, T
    Baczkowski, A
    Geffner, M
    Gupta, S
    Laughlin, M
    HEPATOLOGY, 2005, 42 (05) : 1010 - 1018
  • [44] Cost Effectiveness of Peginterferon Alfa-2b Combined with Ribavirin for the Treatment of Chronic Hepatitis C in Brazil
    Machado Fonseca, Marcelo Cunio
    Branco de Araujo, Gabriela Tannus
    Araujo, Denizar Vianna
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (03): : 191 - 199
  • [45] Treatment of hepatitis C virus-associated thrombocytopenic purpura with a combination of interferon alfa-2b and ribavirin
    Barel, C
    Bilger, K
    Ninet, J
    Scoazec, JY
    Dumortier, J
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (02) : 200 - 201
  • [46] Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden
    Bernfort, Lars
    Sennfalt, Karin
    Reichard, Olle
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (6-7) : 497 - 505
  • [47] Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin
    Kraus, MR
    Schäfer, A
    Wissmann, S
    Reimer, P
    Scheurlen, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (01) : 90 - 100
  • [48] Interferon alfa-2b and ribavirin in patients with resistant chronic hepatitis C.
    Min, AD
    Jones, JL
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Esposito, S
    Geders, JM
    Tobias, H
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
  • [49] Interferon-alfa2B and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    Rakela, J
    HEPATOLOGY, 1999, 30 (04) : 656A - 656A
  • [50] Interferon-alfa2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    McGuire, B
    Crippin, JS
    Canjeevaram, HS
    Teperman, L
    Gish, RG
    Kwo, P
    Wright, TL
    Brass, C
    Balan, V
    Demetris, J
    Rakela, J
    HEPATOLOGY, 2000, 32 (04) : 216A - 216A
12345